Oncology News International April 2009 Vol. 18 No. 4
Cover Story
Optimal use of aromatase inhibitors comes into focus
Masters of hematology and oncology: David Alberts, MD
DEPARTMENTS
News & Analysis
Pharmaceutical mergers raise fears of treatment pipeline pruning
Prophylaxis fends off life-threatening invasive fungal infections
MR spectroscopy separates brain tumor recurrence from radiation necrosis
Medicare approves coverage of FDG-PET scans for 11 cancers
Cancer Care: Practice & Policy
Two major studies add fuel to fire of PSA controversy
Focus on Prostate Cancer
Evidence grows for value of high-field MRI in prostate cancer Rx
Most prognostic prostate cancer markers lack clinical utility
Focus on Colon Cancer
Minority groups protest CMS rejection of CT-based colon cancer screening
Focus on Hematology
Clear-cut evidence for routine use of ESA agents remains elusive
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
![“These findings highlight the critical need to address PEM in the management of [patients with multiple myeloma] with ACHF to mitigate the associated poor clinical outcomes,” according to the study authors.](/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fcancernetwork%2F4de1e119837b011168a7884a19a600b14bb6a258-3600x2400.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 "“These findings highlight the critical need to address PEM in the management of [patients with multiple myeloma] with ACHF to mitigate the associated poor clinical outcomes,” according to the study authors.")
